Double Blind Randomized Trial News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Double Blind Randomized Trial. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Double Blind Randomized Trial Today - Breaking & Trending Today

Relmada Therapeutics Announces Publication of REL-1017 Phase 2 Study Results in The American Journal of Psychiatry

Published: December 22, 2021

/PRNewswire/ -- Relmada Therapeutics, Inc. (NASDAQ: RLMD), a late-stage biotechnology company addressing diseases of the central nervous system (CNS), today...

Source: prnewswire.com

Related Topics:

United StatesPaolol ManfrediSergio TraversaTim MccarthyRelmada Therapeutics IncClinical Research ProgramTherapeutics IncDepartment Of Psychiatry At MassachusettsSecurities ExchangeRelmada TherapeuticsAmerican JournalAdjunctive TreatmentMajor Depressive DisorderDouble Blind Randomized TrialChief Scientific OfficerAsberg Depression ScaleMaurizio FavaPrincipal InvestigatorMassachusetts General HospitalChief ExecutiveResearch ProgramPrivate Securities Litigation Reform ActSecurities ActSecurities Exchange Act

Relmada Therapeutics to Present Data at the Neuroscience Education Institute Congress

Published: October 29, 2021

/PRNewswire/ -- Relmada Therapeutics, Inc. (Nasdaq: RLMD), a late-stage biotechnology company addressing diseases of the central nervous system (CNS), today...

Source: prnewswire.com

Related Topics:

Tim MccarthyClinical Research ProgramVirtual Poster LibraryNeuroscience Education InstituteRelmada Therapeutics IncTherapeutics IncSecurities ExchangeAntidepressant In Clinical DevelopmentColorado SpringsPoster LibraryAdjunctive TreatmentMajor Depressive DisorderDouble Blind RandomizedDouble Blind Randomized TrialCase ReportMajor DepressiveRapid Acting AntidepressantClinical DevelopmentHuman Abuse PotentialReinforcement Type BehaviorPhysical DependenceSprague DawleyHuman Heterodimericn Methyld AspartateDid Not Produce InitialCumulative Neurotoxic Effects